Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Red blood cell membrane defects.

Achille Iolascon1, Silverio Perrotta, Gordon W Stewart

  • 1Institute for Pediatrics, University of Foggia, Viale Pinto, 71100 Foggia, Italy.

Reviews in Clinical and Experimental Hematology
|December 25, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EHA Recommendations for preconceptual and antenatal screening and prenatal diagnosis for hemoglobinopathies.

HemaSphere·2026
Same author

A new 308 A-G substitution in HBG2 in an acyanotic newborn: case report.

Italian journal of pediatrics·2026
Same author

Clinical variability of ATP11C-related hemolytic anemia: expanding the phenotypic and diagnostic spectrum.

Blood advances·2026
Same author

Refined classification and phenotype-driven analysis of PIEZO1 variants in hereditary red cell and iron disorders.

Blood·2026
Same author

Revisiting LSDMCA: male lethality escape and genotype-phenotype correlations.

European journal of human genetics : EJHG·2026
Same author

A Complex Neurodevelopmental Phenotype Resembling a Chromatinopathy With Concurrent 7p Duplication and 10p Deletion Involving ZMYND11: A Case Report and Literature Review.

Molecular genetics & genomic medicine·2026
Same journal

Genomics in hematologic malignancies.

Reviews in clinical and experimental hematology·2006
Same journal

Infections in hematologic patients: the future.

Reviews in clinical and experimental hematology·2006
Same journal

Thrombotic problems in hematologic malignancies.

Reviews in clinical and experimental hematology·2006
Same journal

Prophylaxis and treatment of bacterial infections: do we need new strategies?

Reviews in clinical and experimental hematology·2006
Same journal

Recent developments in new and old viral infections.

Reviews in clinical and experimental hematology·2006
Same journal

Microbiologic consequences of new approaches to managing hematologic malignancies.

Reviews in clinical and experimental hematology·2006
See all related articles

Red cell membrane disorders like hereditary spherocytosis and elliptocytosis stem from genetic mutations affecting erythrocyte structure and function. Understanding these molecular bases is key to diagnosing and managing these inherited blood conditions.

Area of Science:

  • Hematology
  • Molecular Biology
  • Genetics

Background:

  • Red cell membrane disorders are a group of inherited conditions affecting erythrocyte structure and function.
  • These disorders can lead to various clinical manifestations, including anemia and increased risk of complications.

Purpose of the Study:

  • To provide an overview of the molecular basis of red cell membrane disorders.
  • To discuss the structure, pathophysiology, and clinical aspects of these conditions.

Main Methods:

  • Review of current literature on red cell membrane disorders.
  • Detailed discussion of genetic mutations and their encoded proteins.
  • Exploration of pathophysiology and clinical presentations.

Main Results:

Related Experiment Videos

  • Hereditary spherocytosis (HS) is linked to mutations in genes encoding ankyrin, spectrins, band 3, and protein 4.2, causing loss of erythrocyte surface area.
  • Hereditary elliptocytosis (HE) and hereditary pyropoikilocytosis (HPP) involve mutations in SPTA1, SPTB, and EPB41 genes, affecting skeletal elasticity.
  • Southeast Asian ovalocytosis is associated with changes in band 3; channelopathies are emerging as a new area for membrane permeability disorders.

Conclusions:

  • Genetic mutations in specific proteins are the primary cause of hereditary red cell membrane disorders.
  • Understanding these molecular defects is crucial for accurate diagnosis and management.
  • Further research into channelopathies offers new insights into membrane transport disorders.